Drugs & Medications

Nanoparticle Enhanced Radiotherapy (NERT) for Brain Tumor Treatment (2024 Research)

by

Nanoparticle-enhanced radiotherapy (NERT) is a promising approach to improving brain tumor treatment by enhancing radiotherapy efficacy through targeted delivery and radiosensitization while overcoming challenges posed by the blood-brain barrier. Highlights: Mechanisms of Action: NERT utilizes nanoparticles (NPs) as radiosensitizers, enhancing radiation-induced damage through physical dose enhancement and biological/chemical sensitization. Types of Nanoparticles: Various NP types, …

Read more

Cocaine Addiction Linked to Brain Shrinkage & Grey Matter Deficits (2024 Study)

by

Cocaine Use Disorder (CUD) patients exhibit widespread gray matter atrophy, with specific brain volume deficits associated with crack-cocaine use and relapse outcomes. Highlights: Widespread Gray Matter Atrophy: CUD patients show significant gray matter volume reductions in frontal and temporal cortices, cerebellum, and subcortical structures compared to healthy controls. Route of Use: Crack-cocaine use is linked …

Read more

OCD Treatment with Antidepressants (SSRIs) Alters Brain Structure & Functions (2024 Study)

by

Antidepressant treatment in OCD is linked to structural and functional brain changes, particularly in corticosubcortical areas, but these findings need further validation in larger, more homogeneous samples. Highlights: Antidepressant Use: Antidepressants, especially SSRIs, are a primary treatment for OCD, resulting in significant brain changes. Brain Structure Changes: Studies show volume alterations in the thalamus, amygdala, …

Read more

Lithium Appears Neuroprotective in Traumatic Brain Injury (TBI) (2024 Research)

by

Lithium shows promise in treating traumatic brain injury (TBI) by mitigating neuroinflammation, protecting against neuronal damage, and improving cognitive functions. Highlights: Neuroprotective Mechanisms: Lithium’s therapeutic effects involve complex molecular mechanisms including gene expression, neurotransmitter signaling, and circadian modulation, contributing to neuronal protection and recovery post-TBI. Targeted Brain Regions: Post-treatment, lithium concentrations are notably higher in …

Read more

Selegiline Reverses Anxiety & Memory Impairment in Amyloid Beta-Induced Alzheimers Model Rats (2024 Study)

by

The study demonstrated that selegiline (SEL) improves memory performance, reduces anxiety, and modulates oxidative stress in an Alzheimer’s disease (AD) rat model. Highlights: Memory Improvements: SEL administration improved recognition memory, spatial memory, and passive avoidance memory in AD rats. Anxiety Reduction: SEL significantly reduced anxiety-like behavior in AD rats, as evidenced by performance in the …

Read more

Repurposing Antipsychotics & Antidepressants to Treat Glioblastoma (2024 Study)

by

Repurposing antipsychotics and antidepressants with favorable safety profiles and blood-brain barrier permeability shows promise for glioblastoma (GBM) treatment, primarily through disrupting lysosomal function and inducing cell death. Highlights: Mechanism of Action: The studied antipsychotics and antidepressants induce GBM cell death by disrupting lysosomal function, leading to lysosomal membrane rupture. PTEN Sensitivity: GBMs with intact PTEN …

Read more

Drug-Induced Musical Hallucinations: Causes & Treatments (2024 Research)

by

Drug-induced musical hallucinations occur across various medical conditions, with antidepressants, opioids, and other medications as common triggers, potentially arising from neurotransmitter imbalances; treatment often involves modifying or discontinuing the trigger drug. Highlights: Prevalence & Demographics: The average patient age was 58.3 years, with 67.9% being female. Common Conditions: Hearing impairments, psychiatric disorders, cancers, and neurodegenerative …

Read more

Intranasal Insulin for Mild Cognitive Impairment: Enhancing Social Skills, Memory, Grey Matter Volume (2024 Case Report)

by

Extended intra-nasal insulin (INI) treatment in an insulin-resistant early Mild Cognitive Impairment (MCI) patient improved grey matter volume, reduced beta-amyloid levels, and enhanced cognitive and pragmatic capacities, suggesting potential to slow neurodegenerative disease progression. Highlights: Grey Matter Volume: After 9 months of INI treatment, the patient experienced an increase in grey matter volume. Beta-Amyloid Levels: …

Read more

Ketamine Rapidly Reverses Suicidal Ideation & Severe Depression (2024 Meta-Analysis)

by

Ketamine significantly reduces suicidal ideation in depressed patients, with rapid effects observed within the first day of treatment. Highlights: Rapid Reduction: Ketamine shows a significant reduction in suicidal ideation within the first day of treatment (RR = 10.02, 95% CI = 4.24 to 23.68). Sustained Improvement: Repeated ketamine treatments result in a greater reduction of …

Read more

Serotonin (5-HT) vs. Tumors & Cancers: Potential Immunomodulation Treatment (2024 Research)

by

Cancer patients frequently experience depressive symptoms, and the role of serotonin in tumor regulation varies across different types. Highlights: Prevalence of Depression in Cancer Patients: A significant portion of cancer patients experience depressive symptoms, which are often linked to neuroendocrine hormone imbalances and decreased serotonin levels. Neuroimmunology’s Role: Neuroimmunology is an emerging field that has …

Read more

+ Load more